Cassie Homer - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Cassie Homer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Cassie Homer
Verified
Senior Managing Editor, MD/alert
Philadelphia
Beats
Mental health, Education Spirituality, and More. Tech, Parenthood LGBTQ+ identity, Sex work Justice movements
Content
By Cassie Homer Verified| MD/alert@ By Cassie Homer, Senior Managing Editor Save to PDF April 12, 2022 By <em>By Cassie Homer, Senior Managing Editor</em> The FDA granted HPN328, a delta like ligand 3 (DLL3) targeting therapy, orphan drug designation for the treatment of patients with small cell lung cancer, according to a press release from the manufacturer. The manufacturer used its Tri-specific T cell Activating Construct (TriTAC) platform to develop the drug. An open-label phase 1/2 trial is underway to assess the safety...
By Cassie Homer Verified| HemOnc Today Verified Receive an email when new articles are posted on this topic . Please provide your email address to receive an email when new articles are posted on this topic . About 25% of genetic variants of uncertain significance detected in testing for hereditary cancer risk were later reclassified as benign or pathogenic, according to a retrospective study that assessed 10 years of data from a single institution.
By Cassie Homer Verified| MD/alert@ By Cassie Homer, Senior Managing Editor Save to PDF April 12, 2022 By <em>By Cassie Homer, Senior Managing Editor</em> The FDA granted HPN328, a delta like ligand 3 (DLL3) targeting therapy, orphan drug designation for the treatment of patients with small cell lung cancer, according to a press release from the manufacturer. The manufacturer used its Tri-specific T cell Activating Construct (TriTAC) platform to develop the drug. An open-label phase 1/2 trial is underway to assess the safety...
Company Info
MD/alert
Philadelphia, United States